Analysis of Down syndrome failed to be diagnosed after prenatal screening A multicenter study

被引:7
|
作者
Jiang, Tao [1 ]
Ding, Jie [2 ]
Zhang, Xiao-Qing [3 ]
Zhang, Xiao-Juan [1 ]
Zhang, Bin [3 ]
Wang, Ting [2 ]
Yu, Bin [3 ]
机构
[1] Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Suzhou Municipal Hosp, Suzhou 215000, Peoples R China
[3] Nanjing Med Univ, Changzhou Woman & Children Hlth Hosp, Changzhou 213003, Jiangsu, Peoples R China
关键词
biomarkers; Down syndrome; missed diagnosis; prenatal diagnosis; prenatal screening; serum; FREE BETA-HCG; 2ND TRIMESTER; ALPHA-FETOPROTEIN;
D O I
10.1097/MD.0000000000007166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To analyze the characters of Down syndrome (DS) who failed to be diagnosed after prenatal screening and hope to be able to improve the programs of prenatal screening and reduce the missed diagnosis of DS. In this multicenter study, we collected the missed cases from 3 prenatal diagnosis centers and analyzed their characters. A total of 126 DS babies failed to be diagnosed after prenatal screening. Their mothers accepted the prenatal screening in second trimester. We collected the mothers' blood and detected the levels of alpha-fetoprotein (AFP) and the free beta subunit of human chorionic gonadotropin (f beta hCG) by time-resolved fluoroimmunoassay. The values were also presented as multiples of the median (MoM) and determined the risk of carrying a fetus with DS by Wallace LifeCycle Elipse analysis software. Compared with normal control group, the level of fbhCG and hCG MoM were dramatically increased, while AFP and AFP MoM were decreased. The area under the receiver-operating-characteristic curve of trisomy 21 was 0.8387 for hCG-MoM and AFP-MoM testing. The sensitivity, specificity, positive predictive value, and negative predictive value were 84.6%, 74.8%, 75.4%, and 83.6%, respectively. Meanwhile, the prediction mode was '' 0.39957+1.90897(*) HCG-MOM -3.32713(*) AFP-MOM". It was worthwhile noting that the risk of 65.9% DS missed diagnosis group were higher than 1/1000, 92.9% higher than 1/3000. However, 72.5% cases in normal control group were lower than 1/3000. Only 9.2% mothers would be higher than the value of risk in 1/1000. The prediction mode of hCG MoM and AFP MoM might be able to help us reduce the missed diagnosis. It is also necessary to adjust more reasonable range of noninvasive prenatal testing with further clinical researches.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Circulating MicroRNAs in the Screening of Prenatal Down Syndrome
    Balci, Senay
    Cayan, Filiz
    Ozdemir, Gurbet Dogru
    Ay, Mustafa Ertan
    Yildirim, Didem Derici
    Tamer, Lulufer
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2023, 42 (03) : 219 - 225
  • [2] Serological prenatal screening and diagnosis for Down syndrome
    Duan, Y.
    Li, Y.
    Xue, Q.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2014, 41 (05) : 572 - 574
  • [3] Prenatal screening for Down's syndrome with maternal markers: Tunisian experience
    Ferchichi, S.
    Chahed, H.
    Jaidane, Z.
    Chaabouni, Y.
    Saafi, N.
    Limem, H. B.
    Sakouhi, M.
    Bernard, M.
    Khairi, H.
    Laradi, S.
    Miled, A.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2010, 25 (04): : 205 - 211
  • [4] Economic analysis of prenatal screening strategies for Down syndrome in singleton pregnancies in Turkey
    Okem, Zeynep Culdem
    Orgul, Gokcen
    Kasnakoglu, Berna Tari
    Cakar, Mehmet
    Beksac, M. Sinan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 219 : 40 - 44
  • [5] Proteomic techniques for finding biomarkers for prenatal screening for Down syndrome: where are we?
    Wang, Qiu-Wei
    Yu, Bin
    EXPERT REVIEW OF PROTEOMICS, 2012, 9 (06) : 583 - 585
  • [6] Significance of data analysis in the quality control of prenatal screening for Down syndrome
    Li, Yahong
    Zhang, Xiaojuan
    Hong, Dongyang
    Guan, Xianwei
    Lv, Shaolei
    Sun, Yun
    Jiang, Tao
    BIOMEDICAL REPORTS, 2018, 8 (05) : 447 - 453
  • [7] Clinical strategy study on prenatal screening and diagnostic model for Down syndrome
    Luo, Wei
    Liu, Sha
    He, Bin
    Han, Daiwen
    Yuan, Lixing
    Zhao, Kai
    Tang, Jun
    Pang, Ling
    Zou, Fene
    Liu, Jianlong
    Liu, Hongqian
    Bai, Ting
    Jing, Xiaosha
    Xia, Tianyu
    Deng, Cechuan
    Liu, Yunyun
    Cheng, Jing
    Wei, Xiang
    Xing, Lingling
    Luo, Yuan
    Zhou, Quanfang
    Zhu, Qian
    Liu, Shanling
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Contingent screening for Down syndrome completed in the first trimester: a multicenter study
    Munoz-Cortes, M.
    Arigita, M.
    Falguera, G.
    Seres, A.
    Guix, D.
    Baldrich, E.
    Acera, A.
    Torrent, A.
    Rodriguez-Veret, A.
    Lopez-Quesada, E.
    Garcia-Moreno, R.
    Gonce, A.
    Borobio, V.
    Borrell, A.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 39 (04) : 396 - 400
  • [9] Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome
    Jaques, Alice M.
    Collins, Veronica R.
    Muggli, Evelyne E.
    Amor, David J.
    Francis, Ivan
    Sheffield, Leslie J.
    Halliday, Jane L.
    PRENATAL DIAGNOSIS, 2010, 30 (06) : 522 - 530
  • [10] Prenatal Screening for Down Syndrome in Australia
    Nisbet, Debbie L.
    McLennan, Andrew
    ULTRASOUND, 2009, 17 (03) : 167 - 170